These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6356894)

  • 21. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O; Spinar J; Tomandl J; Konecny T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Catizone L; Cocchi R; Fusaroli M; Zucchelli P
    Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
    Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
    Kanno Y; Suzuki H; Nakamoto H; Okada H; Sugahara S
    Adv Perit Dial; 2003; 19():143-7. PubMed ID: 14763051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy.
    Mimura T; Takenaka T; Kanno Y; Aoki H; Ohshima J; Suzuki H
    Adv Perit Dial; 2005; 21():139-45. PubMed ID: 16686305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with hemodialysis and peritoneal dialysis.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Contrib Nephrol; 2012; 177():71-83. PubMed ID: 22613917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.
    Oelkers W
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):91-7. PubMed ID: 2982239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
    Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
    Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.
    Miyata T; Ueda Y; Yoshida A; Sugiyama S; Iida Y; Jadoul M; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Mar; 51(3):880-7. PubMed ID: 9067925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on plasma 18-hydroxycorticosterone and aldosterone in sodium depleted conscious rats].
    Yamamoto I; Iwasaki I; Miyauchi E; Azukizawa S; Kigoshi T; Uchida K; Morimoto S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):42-9. PubMed ID: 2407571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.
    Keshaviah P; Collins AJ; Ma JZ; Churchill DN; Thorpe KE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S48-52. PubMed ID: 11792762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells.
    Mettang T; Fritz P; Weber J; Machleidt C; Hübel E; Kuhlmann U
    Clin Nephrol; 1990 Sep; 34(3):136-41. PubMed ID: 1699691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.